Search

Your search keyword '"Maggi L"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Maggi L" Remove constraint Author: "Maggi L" Topic medicine Remove constraint Topic: medicine
60 results on '"Maggi L"'

Search Results

1. Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study

2. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

3. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

4. Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

5. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

6. A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

7. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

8. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study

9. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

10. LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population

11. Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients

12. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients

13. A Randomized Trial of the Impact of Certified Mail on Response Rate to a Physician Survey, and a Cost-Effectiveness Analysis

14. Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis

15. Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open non comparative phase 2 multicenter Italian study (After-6 Protocol 2)

16. Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients

17. The Role of Psychomotor Activation in Discriminating Unipolar From Bipolar Disorders

18. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders

19. Probenecid and benzamide: cocrystal prepared by a green method and its physico-chemical and pharmaceutical characterization

20. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization

21. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

22. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

23. Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease

24. Flower-visiting and pollen-carrying arthropods of Leucojum aestivum L. (Amaryllidaceae) in wild, reintroduced and ex situ populations

25. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis

26. SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy

27. Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients

28. Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis

29. Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

30. Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes

31. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

32. A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy

33. Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease

34. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection

35. Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction

36. Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment

37. Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients

38. Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis

39. P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study

40. Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization

41. Propofol sedation reduces diaphragm activity in spontaneously breathing patients: ultrasound assessment

42. Biobank of Cells, Tissues and DNA from Patients with Neuromuscular Diseases: An Indispensable link between Clinical Centers and the Scientific Community

43. Cardiac and Neuromuscular Features of Patients WithLMNA-Related Cardiomyopathy

44. The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients

45. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients

46. Muscle MRI findings in facioscapulohumeral muscular dystrophy

47. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination

48. Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells

49. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort

50. Mechanochemical synthesis of bumetanide-4-aminobenzoic acid molecular cocrystals: a facile and green approach to drug optimization

Catalog

Books, media, physical & digital resources